SHAREHOLDERS' EQUITY: (Details 4) (USD $)	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Apr. 30, 2012
Number Of Shares
Outstanding at the beginning of the period (in shares)	52,500
Outstanding at the end of the period (in shares)	52,500	52,500
Restricted stock grants
Stock compensation expense	$ 200,000	$ 200,000
Number of shares of common stock reserved for issuance	777,347
Exercise price of warrants (in dollars per share)			1.30
Restricted Stock
Number Of Shares
Outstanding at the beginning of the period (in shares)	52,500
Granted (in shares)	52,500
Issued (in shares)	(52,500)
Cancelled (in shares)	0
Outstanding at the end of the period (in shares)	52,500
Weighted Average Fair Value Grant-Date
Outstanding at the beginning of the period (in dollars per share)	$ 2.85
Granted (in dollars per share)	$ 1.03
Issued (in dollars per share)	$ 1.03
Cancelled (in dollars per share)	$ 0
Outstanding at the end of the period (in dollars per share)	$ 2.85
Restricted stock grants
Granted (in shares)	52,500
Unrecognized compensation costs related to non-vested non-performance based restricted stock awards	150,000
Restricted Stock | Non-employee directors
Number Of Shares
Granted (in shares)	52,500
Restricted stock grants
Granted (in shares)	52,500
Stock compensation expense	$ 54,000
Warrants | Consultants
Restricted stock grants
Warrants granted to purchase common stock (in shares)	20,000
Exercise price of warrants (in dollars per share)	2.28
Number of equal annual installments in which warrants vest	2